The FDA label recommends switching to a non-oral contraceptive an IUD, implant, or patch OR adding a barrier method during those four-week windows after starting or stepping up the dose
Tirzepatide delays gastric emptying
Understanding what to do when tirzepatide stops working or why you might not lose weight in the first four weeks on semaglutide can help determine whether a switch is truly needed or whether adjustments to the current medication might solve the problem
Peptide: Tirzepatide 5mg Tirzepatide 5mg is a lower-fill research presentation of a dual GIP/GLP-1 receptor agonist peptide
Wegovy Important Safety Information: Read more about serious warnings and safety info
You may also see depression, irritability, agitation, high appetite, vivid dreams, and aches and pains